Fri, Mar 29, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index down 3.06% in October (-1.90 YTD)

Friday, November 16, 2018
Opalesque Industry Update - Hedge Funds gave up 3.06% in October according to the Barclay Hedge Fund Index compiled by BarclayHedge, versus a 6.84% decrease in the S&P 500 Total Return Index. Year to date, the Barclay Hedge Fund Index is down 1.90%, while the S&P has gained 3.01%.

"Slowing growth, rising interest rates and trade wars contributed to the largest monthly decline in the S&P 500 since September 2011," says Sol Waksman, founder and president of BarclayHedge. "US equity markets lost approximately $2 trillion in value during the month."

Overall, 16 of Barclay's 17 hedge fund indices had losses in October, while only one index had a gain.

In response to the selloff in tech stocks, the BarclayHedge Technology Index dropped 6.70% in October. Equity Long Bias lost 5.48%, Pacific Rim Equities gave up 3.69%, Healthcare & Biotechnology lost 3.42%, and Emerging Markets were down 3.41%.

"Nasdaq dropped 9.2 percent in October, its worst monthly decline since November 2008 when it lost 10.8 percent. The biggest names in the technology sector-Facebook, Amazon, Apple, Netflix and Google-were among the biggest losers," says Waksman.

The only Barclay Hedge Fund index with a gain in October was Fixed Income Arbitrage, which was up 0.17%.

At the end of October, seven hedge fund indices still have positive returns for the year, while 10 now have losses.

The Healthcare & Biotechnology Index leads all indices with a 13.85% gain, Distressed Securities are up 7.13%, Technology has gained 5.60%, Fixed Income Arbitrage is up 1.95%, and the Convertible Arbitrage Index has gained 1.76%.

Year to date, the Emerging Markets Index has lost 10.68%, Pacific Rim Equities are down 5.57%, the Multi-Strategy Index has lost 2.61%, and Equity Long Bias is down 2.48%.

The Barclay Fund of Funds Index gave up 2.69% in October, and has moved into negative territory with a 2.34% loss for the year.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1